Literature DB >> 30131615

RIP kinases as modulators of inflammation and immunity.

Sudan He1,2,3, Xiaodong Wang4,5.   

Abstract

Receptor-interacting protein (RIP) kinases, in particular RIPK1, RIPK2 and RIPK3, have emerged as pleiotropic modulators of inflammatory responses that act either by directly regulating intracellular inflammatory signaling pathways or by causing apoptotic or necrotic cell death. In this Review, we discuss the signaling pathways and immunological functions of these RIP kinases in the inflammatory response to microbial infection and tissue injury, as well as their potential roles in the pathogenesis of inflammatory disease and aging.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30131615     DOI: 10.1038/s41590-018-0188-x

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  55 in total

1.  The NuRD chromatin-remodeling complex enzyme CHD4 prevents hypoxia-induced endothelial Ripk3 transcription and murine embryonic vascular rupture.

Authors:  Sarah Colijn; Siqi Gao; Kyle G Ingram; Matthew Menendez; Vijay Muthukumar; Robert Silasi-Mansat; Joanna J Chmielewska; Myron Hinsdale; Florea Lupu; Courtney T Griffin
Journal:  Cell Death Differ       Date:  2019-06-24       Impact factor: 15.828

Review 2.  Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases.

Authors:  Ivona Aksentijevich; Oskar Schnappauf
Journal:  Nat Rev Rheumatol       Date:  2021-05-25       Impact factor: 20.543

Review 3.  Necroptosis: a crucial pathogenic mediator of human disease.

Authors:  Mary E Choi; David R Price; Stefan W Ryter; Augustine M K Choi
Journal:  JCI Insight       Date:  2019-08-08

Review 4.  Lytic cell death in metabolic liver disease.

Authors:  Jérémie Gautheron; Gregory J Gores; Cecília M P Rodrigues
Journal:  J Hepatol       Date:  2020-04-13       Impact factor: 25.083

5.  RIP1 kinase inhibitor halts the progression of an immune-induced demyelination disease at the stage of monocyte elevation.

Authors:  Sitao Zhang; Yaning Su; Zhengxin Ying; Dejia Guo; Chenjie Pan; Jia Guo; Ziye Zou; Lei Wang; Ze Zhang; Zhaodi Jiang; Zhiyuan Zhang; Xiaodong Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-05       Impact factor: 11.205

Review 6.  The interplay of autophagy and non-apoptotic cell death pathways.

Authors:  Dannah R Miller; Scott D Cramer; Andrew Thorburn
Journal:  Int Rev Cell Mol Biol       Date:  2020-01-13       Impact factor: 6.813

7.  A phosphorylation of RIPK3 kinase initiates an intracellular apoptotic pathway that promotes prostaglandin-induced corpus luteum regression.

Authors:  Dianrong Li; Jie Chen; Jia Guo; Lin Li; Gaihong Cai; She Chen; Jia Huang; Hui Yang; Yinhua Zhuang; Fengchao Wang; Xiaodong Wang
Journal:  Elife       Date:  2021-05-24       Impact factor: 8.140

Review 8.  Targeting RIP Kinases in Chronic Inflammatory Disease.

Authors:  Mary Speir; Tirta M Djajawi; Stephanie A Conos; Hazel Tye; Kate E Lawlor
Journal:  Biomolecules       Date:  2021-04-28

9.  Enhanced RIPK3 kinase activity-dependent lytic cell death in M1 but not M2 macrophages.

Authors:  Qin Hao; Suman Kundu; Joshua Kleam; Zhizhuang Joe Zhao; Steven Idell; Hua Tang
Journal:  Mol Immunol       Date:  2020-11-18       Impact factor: 4.407

Review 10.  Necroptosis molecular mechanisms: Recent findings regarding novel necroptosis regulators.

Authors:  Jinho Seo; Young Woo Nam; Seongmi Kim; Doo-Byoung Oh; Jaewhan Song
Journal:  Exp Mol Med       Date:  2021-06-01       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.